drug delivery

Pharma

GSK licenses Alteogen enzyme in bid to develop subQ Jemperli

With checkpoint inhibitors like Keytruda and Opdivo now sporting subQ formulations, GSK wants to ensure its own PD-1 drug doesn’t miss out on the action.

Fraiser Kansteiner Jan 20, 2026 2:26pm

AbbVie snaps up device plant amid broader $10B US investment

Jan 12, 2026 9:17am

yellow light street light traffic pause slow delay

Supernus confronts Onapgo supply constraint early into launch

Nov 5, 2025 4:20pm

MA strategy deal block push come together form

Germany's LTS boosts US drug delivery CDMO footprint through M&A

Oct 13, 2025 10:49am

FDA approves Corstasis' nasal spray as treatment for edema

Sep 15, 2025 3:33pm

Saplings growing with increasing denominations of money wrapped around them

Manufacturer PCI snares 'sizable' private equity investment

Jul 15, 2025 8:30am